Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.
Levine
Alexandra M
AM
Shimodaira
Shigetaka
S
Lai
Michael M C
MM
D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D045744:Cell Line, Tumor / Q000821:virology; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell; D020522:Lymphoma, Mantle-Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*; D013160:Splenic Neoplasms / Q000150:complications / Q000188:drug therapy*; D019562:Viral Load
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin